ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,39
-0,59%
Bitcoin
59 694,93
-1,49%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Viatris Inc (VTRS)

  7. Viatris Inc (VTRS) Actualités

VTRS Viatris Inc

11,57
-0,21 (-1,78%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Viatris Inc VTRS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,21 -1,78% 11,57 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,74 11,57 11,75 11,57 11,78
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202422:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
15/4/202414:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
15/4/202412:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
01/4/202412:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
27/3/202411:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
06/3/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202400:11EDGAR2Form 144 - Report of proposed sale of securities
28/2/202413:39EDGAR2Form 8-K - Current report
28/2/202412:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
28/2/202407:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
24/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:18EDGAR2Form 144 - Report of proposed sale of securities
05/2/202412:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
30/1/202422:40EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202412:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
06/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:28EDGAR2Form 144 - Report of proposed sale of securities
21/12/202322:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
16/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:04EDGAR2Form 8-K/A - Current report: [Amend]
15/12/202323:00EDGAR2Form 8-K - Current report
15/12/202322:45PRNUSViatris Continues its Preparations for Phase 2 of its..
15/12/202322:14EDGAR2Form 8-K - Current report
15/12/202322:12EDGAR2Form 8-K - Current report
15/12/202322:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
14/12/202323:31EDGAR2Form 144 - Report of proposed sale of securities
25/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/11/202319:02EDGAR2Form 144 - Report of proposed sale of securities
14/11/202314:00PRNUSViatris to Participate in the Jefferies London Healthcare..
13/11/202314:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
07/11/202322:39EDGAR2Form 8-K - Current report
07/11/202322:02PRNUSViatris Reports Strong Financial and Operational Results for..
03/11/202321:36EDGAR2Form ARS - Annual Report to Security Holders
03/11/202321:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202321:31EDGAR2Form DEF 14A - Other definitive proxy statements
30/10/202314:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
24/10/202322:32EDGAR2Form 8-K - Current report
24/10/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/10/202315:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
20/10/202323:18EDGAR2Form 8-K - Current report
20/10/202323:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
18/10/202314:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
10/10/202315:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

Dernières Valeurs Consultées

NASDAQ
VTRS
Viatris
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés